Transgenic Microalgae Omega-3 Production Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing long chain polyunsaturated fatty acids (LC-PUFAs), particularly omega-3 LC-PUFAs like DHA, in microalgae are inefficient and costly, with the Δ6-desaturation step being rate-limiting in the biosynthetic pathway.
Innovation Solution
Transgenic microalgae are engineered to overexpress the Δ5-elongase from Ostreococcus tauri, leading to increased accumulation of DHA, with levels reaching up to 13% of total fatty acids, and enhancing EPA levels by overexpressing OtD6, thereby optimizing the LC-PUFA biosynthetic pathway through metabolic engineering.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If commercial cultivation of microalgae is used for DHA production, then sustainable omega-3 source is achieved, but production cost is high
Solution Approach 1:
The patent changes the biochemical parameters of microalgae by introducing heterologous genes (Δ6-desaturase, Δ5-elongase, Δ4-desaturase) to alter the fatty acid biosynthesis pathway. This genetic modification shifts the metabolic flux to produce higher levels of DHA and EPA, thereby increasing productivity and reducing production costs while maintaining sustainability
Solution Approach 2:
The patent uses heterologous enzymes from other organisms (Ostreococcus tauri Δ6-desaturase, Fragilariopsis cylindrus Δ5-elongase, Schizochytrium sp. Δ4-desaturase) as intermediaries to catalyze specific steps in the DHA biosynthesis pathway. These intermediary enzymes enable the microalgae to efficiently convert available substrates into target products, improving yield without requiring expensive cultivation conditions
2Productivity
If Δ6-desaturase is overexpressed to increase LC-PUFA production, then omega-3 levels improve, but the rate-limiting step constraint remains
Solution Approach 1:
The patent segments the complex DHA biosynthesis pathway into distinct functional modules, each catalyzed by a specific heterologous enzyme. By dividing the pathway into manageable steps (Δ6-desaturation, Δ5-elongation, Δ4-desaturation) and optimizing each segment separately, the overall pathway efficiency is improved while making the complexity manageable through modular genetic construction
Solution Approach 2:
The patent introduces intermediary enzymes from other organisms that act as catalysts for specific rate-limiting steps in the DHA pathway. These intermediary enzymes (Δ6-desaturase, Δ5-elongase, Δ4-desaturase) mediate the conversion of substrates to products, effectively overcoming the natural rate-limiting constraints of the microalgae's endogenous pathway
3Quantity of substance
If multiple transgenes are introduced to optimize the LC-PUFA pathway, then DHA accumulation increases, but metabolic pathway complexity increases
Solution Approach 1:
The patent divides the multi-step DHA biosynthesis pathway into discrete functional segments, each encoded by a separate heterologous gene. This segmentation allows for independent optimization and characterization of each enzymatic step, enabling precise control over metabolic flux while managing the complexity of introducing multiple transgenes
Solution Approach 2:
The patent employs heterologous enzymes that possess broad substrate specificity and can function effectively in the microalgae host system. These universal enzymes (from Ostreococcus tauri, Fragilariopsis cylindrus, Schizochytrium sp.) can catalyze their respective reactions efficiently in the foreign host, reducing the need for extensive pathway engineering and simplifying the overall genetic construction
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases DHA and EPA production in microalgae, making them a more sustainable and cost-effective source for omega-3 LC-PUFA production, suitable for human nutrition and aquaculture applications.
Implementation Method 1
Transgenic microalgae are engineered to overexpress the Δ5-elongase from Ostreococcus tauri, leading to increased accumulation of DHA
Implementation Method 2
enhancing EPA levels by overexpressing OtD6, thereby optimizing the LC-PUFA biosynthetic pathway
Data Source
Figure 1a~1c
Figure 2a~2b
Figure 3a~3b
AI summary
The invention relates to genetically modified organisms with enhanced production of omega-3 long chain polyunsaturated fatty acids.